7月2日，葛兰素史克盘中上涨3.02%，报53.00美元/股，成交额1425.27万美元。
消息面上，制药板块当日整体表现强势，阿斯利康涨3.9%、诺和诺德涨3.42%，行业情绪明显回暖。与此同时，葛兰素史克旗下子公司此前已正式发起对Nuvalent的要约收购，以每股124美元全现金方式收购其全部流通股，要约截止日期为7月14日。该笔106亿美元的交易是公司十年来最大规模并购，旨在补强肺癌药物管线，Nuvalent董事会已建议股东接受要约。市场对该交易顺利推进的预期以及板块整体回暖，共同推动股价走强。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.